Kolon TissueGene, Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5
Rok finansowy 2019 2020 2021 2022 2023 2024
Przychód (mln) 3,035 3,556 4,003 9,456 3,706 5,073
Przychód Δ r/r 0.0% 17.2% 12.6% 136.2% -60.8% 36.9%
Marża brutto 7.9% 10.6% 10.9% 81.3% 11.1% 11.7%
EBIT (mln) -45,177 -41,556 -46,903 -16,303 -20,504 -21,997
EBIT Δ r/r 0.0% -8.0% 12.9% -65.2% 25.8% 7.3%
EBIT (%) -1488.6% -1168.7% -1171.7% -172.4% -553.3% -433.6%
Koszty finansowe (mln) 1,178 835 466 371 286 90
EBITDA (mln) -47,469 -39,187 -45,134 -7,784 -15,274 -32,996
EBITDA(%) -1564.1% -1102.0% -1127.5% -82.3% -412.1% -650.4%
Podatek (mln) 52 124 218 1,316 253 -95
Zysk Netto (mln) -49,989 -41,788 -47,370 -11,136 -17,224 -33,799
Zysk netto Δ r/r 0.0% -16.4% 13.4% -76.5% 54.7% 96.2%
Zysk netto (%) -1647.2% -1175.2% -1183.3% -117.8% -464.8% -666.2%
EPS -818.2 -684.4 -773.6 -168.0 -240.2 -452.1
EPS (rozwodnione) -818.2 -684.4 -773.6 -168.0 -240.2 -452.1
Ilośc akcji (mln) 61 61 61 66 72 75
Ważona ilośc akcji (mln) 61 61 61 66 72 75
Waluta KRW KRW KRW KRW KRW KRW